MESO Mesoblast Limited American Depositary Shares Biological Products, (No Diagnostic Substances) Best Biotech Stocks 2026 →

Mesoblast (MESO) Stock: Buy, Sell, or Hold?

$13.99
-0.45 (-3.12%) â–ŧ
5d: -5.28% 30d: -1.96% 90d: -16.63%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
34/100
Position
FAIR
30-Day Fair Range
$12.86 – $14.64
Position: FAIR
Forward P/E & Valuation
-233.2x CHEAP
vs 206.7x historical avg
Wall Street Target
$37.00
+164.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$13.12 / $15.82
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: MESO is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When MESO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: MESO is currently trading at $13.99, which is considered fair relative to its 30-day fair value range of $12.86 to $14.64. From a valuation perspective, the stock is trading at a discount (Forward PE: -233.2) compared to its historical average (206.7). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, MESO is in a downtrend. Immediate support is located at $13.12, while resistance sits at $15.82. Short-term momentum is weak, with the stock down 3.1% recently.

Market Sentiment: MESO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.00 (+164.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $12.86 - $14.64
Company Quality Score 34/100 (SELL)
Volume Confirmation HIGH
Confidence Score 50.0%

Trading Range & Key Levels

30-Day Trading Range $12.86 - $14.64
Current vs Trading Range FAIR
Support Level $13.12
Resistance Level $15.82
Current Trend Downtrend
Technical data as of Nov 10, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (15/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.1%)
  • BULLISH: Trading 164.5% below Wall St target ($37.00)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -233.17
Wall Street Target $37.00 (+164.5%)
Revenue Growth (YoY) 390.7%
Profit Margin -47.8%
PE vs Historical -233.2 vs 206.7 CHEAP
Share MESO Analysis

Share this live MESO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (MESO)

Bullish 1 Retail Mentions
Reddit / WSB Comments
1
Bullish
Last Tracked
Sep 20, 2024
Daily AI digest
AI Retail Discussion Summary: Reddit & WallStreetBets discussions on MESO are bullish (sentiment score +0.71) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:06 AM ET
Data refreshes hourly during market hours. Next update: 10:06 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for MESO.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical â€Ļ
STRONG BUY
28 analysts
$91 51 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
22 analysts
$266 60 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 53 HOLD
RAPP
Rapport Therapeutics, Inâ€Ļ
STRONG BUY
16 analysts
$64 58 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
22 analysts
$107 41 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive MESO Research Pages
MESO Technical Chart MESO Price Prediction MESO Intrinsic Value DCF MESO Earnings Date MESO Investment Advisor MESO Fair Price Analyzer MESO Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals